Skip to content

Optimization Research of Clinical treatment Scheme of traditional Chinese Medicine for multiple Sclerosis

Optimization Research of Clinical treatment Scheme of traditional Chinese Medicine for multiple Sclerosis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004480
Enrollment
Unknown
Registered
2020-11-15
Start date
2020-11-16
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple sclerosis

Interventions

Sponsors

Beijing Tiantan Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Subjects aged 18-60 years old; 2. Subjects who met the modified McDonald's criteria for MS diagnosis in 2017; 3. Patients with acute disease; 4. Patients with written informed consent.

Exclusion criteria

Exclusion criteria: 1. The patients who are allergic or contraindicated to the drugs such as hormone and some components of traditional Chinese medicine in the treatment plan; 2. Patients with HIV infection or active hepatitis A or syphilis infection; with history or signs of immunodeficiency; 3. Epileptic patients who failed to fully control after treatment; 4. Patients with serious systemic diseases such as heart, lung, liver, kidney and blood system; 5. Patients with history of severe depression or suicide attempt or suicidal tendency at present; 6. Patients during pregnancy or lactation; 7. Patients with serious adverse reactions during the treatment, making the treatment unable to continue; 8. Patients who use drugs that may affect the test results; 9. Patients who fail to complete all treatment plans or quit halfway as required; 10. Any other circumstances that the researcher considers unsuitable for the trial.

Design outcomes

Primary

MeasureTime frame
Total marked effective rate;

Secondary

MeasureTime frame
annualized relapse rate;Multiple Sclerosis Impact Scale;expanded disability status scale;

Countries

China

Contacts

Public ContactFan Yongping

Beijing Tiantan Hospital Affiliated to Capital Medical University

yongpingf@hotmail.com+86 10-59976665

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026